Skip to content
ppharmaranks
Menu
Class IIOngoing

PeriGuard Ointment recall

FDA recall D-0173-2026 · initiated Aug 27, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Nov 26, 2025How we research

DermaRite Industries, LLC recalled PeriGuard Ointment in Aug 2025 — an FDA Class II recall (D-0173-2026) because CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

All lots on or before expiry date 08/2027

Quantity recalled: 381,619 units

Details

Product
PeriGuard Ointment, Petrolatum 49.9%, packaged in a) 5g (NDC 61924-205-05), b) 3.5oz (NDC 61924-205-04), and c) 7oz (NDC 61924-205-07) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
Recalling company
DermaRite Industries, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Aug 27, 2025
FDA report date
Nov 26, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was PeriGuard Ointment recalled?
DermaRite Industries, LLC recalled PeriGuard Ointment in Aug 2025 — an FDA Class II recall (D-0173-2026) because CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. May cause temporary or medically reversible harm; low probability of serious harm.
Why was PeriGuard Ointment recalled?
Per the FDA enforcement record, the reason for recall D-0173-2026 was: CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Is a recalled PeriGuard Ointment dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of PeriGuard Ointment are affected?
Distributed: Nationwide in the USA. The recall covers these lots — All lots on or before expiry date 08/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0173-2026.

Source: openFDA Drug Enforcement record D-0173-2026

← All drug recalls